-
Something wrong with this record ?
Importance of microbial defence systems to bile salts and mechanisms of serum cholesterol reduction
Š. Horáčková, M. Plocková, K. Demnerová,
Language English Country England, Great Britain
Document type Journal Article, Review
- MeSH
- Amidohydrolases metabolism MeSH
- Bifidobacterium physiology MeSH
- Cell Wall metabolism MeSH
- Cholesterol blood MeSH
- Cytoplasm MeSH
- Lactobacillus physiology MeSH
- Humans MeSH
- DNA Damage MeSH
- Probiotics pharmacology MeSH
- Gastrointestinal Microbiome physiology MeSH
- Bile Acids and Salts metabolism MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
An important feature of the intestinal microbiota, particularly in the case of administered probiotic microorganisms, is their resistance to conditions in the gastrointestinal tract, particularly tolerance to and growth in the presence of bile salts. Bacteria can use several defence mechanisms against bile, including special transport mechanisms, the synthesis of various types of surface proteins and fatty acids or the production of exopolysaccharides. The ability to enzymatically hydrolyse bile salts occurs in a variety of bacteria. Choloylglycine hydrolase (EC 3.5.1.24), a bile salt hydrolase, is a constitutive intracellular enzyme responsible for the hydrolysis of an amide bond between glycine or taurine and the steroid nucleus of bile acids. Its presence was demonstrated in specific microorganisms from several bacterial genera (Lactobacillus spp., Bifidobacterium spp., Clostridium spp., Bacteroides spp.). Occurrence and gene arrangement encoding this enzyme are highly variable in probiotic microorganisms. Bile salt hydrolase activity may provide the possibility to use the released amino acids by bacteria as sources of carbon and nitrogen, to facilitate detoxification of bile or to support the incorporation of cholesterol into the cell wall. Deconjugation of bile salts may be directly related to a lowering of serum cholesterol levels, from which conjugated bile salts are synthesized de novo. Furthermore, the ability of microorganisms to assimilate or to bind ingested cholesterol to the cell wall or to eliminate it by co-precipitation with released cholic acid was also documented. Some intestinal microflora produce cholesterol reductase that catalyses the conversion of cholesterol to insoluble coprostanol, which is subsequently excreted in faeces, thereby also reducing the amount of exogenous cholesterol.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19012976
- 003
- CZ-PrNML
- 005
- 20190405092639.0
- 007
- ta
- 008
- 190405s2017 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.biotechadv.2017.12.005 $2 doi
- 035 __
- $a (PubMed)29248683
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Horáčková, Šárka $u Department of Dairy, Fat and Cosmetics, University of Chemistry and Technology, Technická 5, 166 28 Prague, Czech Republic. Electronic address: sarka.horackova@vscht.cz.
- 245 10
- $a Importance of microbial defence systems to bile salts and mechanisms of serum cholesterol reduction / $c Š. Horáčková, M. Plocková, K. Demnerová,
- 520 9_
- $a An important feature of the intestinal microbiota, particularly in the case of administered probiotic microorganisms, is their resistance to conditions in the gastrointestinal tract, particularly tolerance to and growth in the presence of bile salts. Bacteria can use several defence mechanisms against bile, including special transport mechanisms, the synthesis of various types of surface proteins and fatty acids or the production of exopolysaccharides. The ability to enzymatically hydrolyse bile salts occurs in a variety of bacteria. Choloylglycine hydrolase (EC 3.5.1.24), a bile salt hydrolase, is a constitutive intracellular enzyme responsible for the hydrolysis of an amide bond between glycine or taurine and the steroid nucleus of bile acids. Its presence was demonstrated in specific microorganisms from several bacterial genera (Lactobacillus spp., Bifidobacterium spp., Clostridium spp., Bacteroides spp.). Occurrence and gene arrangement encoding this enzyme are highly variable in probiotic microorganisms. Bile salt hydrolase activity may provide the possibility to use the released amino acids by bacteria as sources of carbon and nitrogen, to facilitate detoxification of bile or to support the incorporation of cholesterol into the cell wall. Deconjugation of bile salts may be directly related to a lowering of serum cholesterol levels, from which conjugated bile salts are synthesized de novo. Furthermore, the ability of microorganisms to assimilate or to bind ingested cholesterol to the cell wall or to eliminate it by co-precipitation with released cholic acid was also documented. Some intestinal microflora produce cholesterol reductase that catalyses the conversion of cholesterol to insoluble coprostanol, which is subsequently excreted in faeces, thereby also reducing the amount of exogenous cholesterol.
- 650 _2
- $a amidohydrolasy $x metabolismus $7 D000581
- 650 _2
- $a Bifidobacterium $x fyziologie $7 D001644
- 650 _2
- $a žlučové kyseliny a soli $x metabolismus $7 D001647
- 650 _2
- $a buněčná stěna $x metabolismus $7 D002473
- 650 _2
- $a cholesterol $x krev $7 D002784
- 650 _2
- $a cytoplazma $7 D003593
- 650 _2
- $a poškození DNA $7 D004249
- 650 _2
- $a střevní mikroflóra $x fyziologie $7 D000069196
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a Lactobacillus $x fyziologie $7 D007778
- 650 _2
- $a probiotika $x farmakologie $7 D019936
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Plocková, Milada $u Department of Dairy, Fat and Cosmetics, University of Chemistry and Technology, Technická 5, 166 28 Prague, Czech Republic. Electronic address: milada.plockova@vscht.cz.
- 700 1_
- $a Demnerová, Kateřina $u Department of Biochemistry and Microbiology, University of Chemistry and Technology, Technická 5, 166 28 Prague, Czech Republic. Electronic address: katerina.demnerova@vscht.cz.
- 773 0_
- $w MED00000793 $t Biotechnology advances $x 1873-1899 $g Roč. 36, č. 3 (2017), s. 682-690
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29248683 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190405 $b ABA008
- 991 __
- $a 20190405092649 $b ABA008
- 999 __
- $a ok $b bmc $g 1392286 $s 1051281
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 36 $c 3 $d 682-690 $e 20171214 $i 1873-1899 $m Biotechnology advances $n Biotechnol Adv $x MED00000793
- LZP __
- $a Pubmed-20190405